Can older adults with heart failure safely stop beta-blockers?
Part of Heart & circulation clinical trials.
This trial tests whether it is safe to gradually stop beta-blocker medication in older adults with heart failure with preserved ejection fraction (a type of heart failure where the heart pumps normally but is stiff). It aims to improve quality of life by reducing unnecessary medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older
- You have heart failure with preserved ejection fraction (HFpEF) — your heart's pumping strength is normal
- You have been hospitalized for heart failure in the past 2 years
- You take one of these beta-blockers: atenolol, bisoprolol, carvedilol, metoprolol succinate, or metoprolol tartrate
- You are a member of Kaiser Permanente Northern California
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether people whose heart function has returned to normal after heart failure can safely stop taking beta-blockers. It aims to see if staying on the medication is still needed or if stopping is just as safe.
This study looks at an “informed” approach to help manage HFpEF (a type of heart failure) in people age 65 and older. It checks whether a structured plan and monitoring are practical and safe for you over time.
This study helps older adults with heart failure gradually increase their beta-blocker dose to a level that guidelines recommend, using an approach tailored to each person.
This trial is testing whether people whose heart failure has improved (with better pumping strength) can safely stop taking some of their heart medications. It is for stable patients who have had significant improvement in their heart function from a low point.
This trial tests whether it is safe to slowly reduce some heart failure medications for people whose heart function has improved to normal. It is for patients who once had a weak heart pump but now have recovered strength and are stable on multiple medicines.
This study tests whether patients whose heart failure has improved can safely reduce some of their medications. If your heart function has recovered significantly and stayed stable, this trial explores whether you can gradually lower doses of heart failure drugs while staying healthy.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.